ASH Guidelines Provide Key Recommendations for AYA Acute Lymphoblastic Leukemia Management: With Wendy Stock, MD

Season 16, Episode 30,   Mar 20, 06:35 PM

Subscribe

Wendy Stock, MD, outlines key recommendations in the 2026 ASH Guidelines for adolescent/young adult acute lymphoblastic leukemia.

In today’s episode, we welcomed Wendy Stock, MD, to discuss key recommendations from the ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults, which were published in February. Stock is the Anjuli Seth Nayak Professor of Medicine at University of Chicago Medicine and co-leader of the Clinical and Experimental Therapeutics research program at the University of Chicago Medicine Comprehensive Cancer Center in Illinois.

In our exclusive interview, Dr Stock explained how specialists, including hematologists, adolescent/young adult (AYA) psychosocial care specialists, pharmacists, methodologists, and patient representatives, contributed to the formation of the ASH AYA ALL guidelines, discussed key recommendations in the guidelines supported by evidence, and detailed how these guidelines can aid in AYA ALL management.